Applying the ASCO and ESMO Value Frameworks to nasopharyngeal cancer treatments: Is adding induction chemotherapy or adjuvant chemotherapy to concurrent chemoradiotherapy worthwhile?

Teng Hwee Tan,Yu Yang Soon,Timothy Cheo,Lea Choung Wong,Yiat Horng Leong,Jeremy Tey,Francis Ho

Applying the ASCO and ESMO Value Frameworks to nasopharyngeal cancer treatments: Is adding induction chemotherapy or adjuvant chemotherapy to concurrent chemoradiotherapy worthwhile?

2020

Teng Hwee Tan
Yu Yang Soon
Timothy Cheo
Lea Choung Wong
Yiat Horng Leong
Jeremy Tey
Francis Ho

67Background: To determine and compare the incremental clinical benefit (ICB) and costs of induction chemotherapy (IC) when added to concurrent chemoradiotherapy (CCRT), concurrent chemotherapy (CC...

Keywords:

Induction chemotherapy
Oncology
Internal medicine
concurrent chemoradiotherapy
nasopharyngeal cancer
concurrent chemotherapy
adjuvant chemotherapy
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations